IP Library Granted Patent US 7,937,159
Granted Patent B2
US 7,937,159 · App. 12/752,931 · Granted May 3, 2011

Apparatus, system and method for therapeutic treatment of obstructive sleep apnea

Assignee: ImThera Medical Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,937,159
App. No.
12/752,931
Granted
May 3, 2011
Kind
B2
Abstract

An implantable neurostimulator for treating obstructive sleep apnea comprises an implant configured to at least partially surround a Hypoglossal nerve (HGN) and a plurality of electrodes each attached to the implant. Each electrode configured to contact the HGN and electrically stimulate one or more regions or groups of the HGN.

Claims (63)

1. An implantable neurostimulator system for treating obstructive sleep apnea, comprising:

an implant having a top and a bottom layer, the bottom layer serving as an attachment mechanism such that the bottom layer of the implant is adapted to be coupled to and at least partially surround a Hypoglossal nerve (HGN) and attaches to the top layer of the implant;

a printed circuit board (PCB) attached to the top layer of the implant, the PCB having a first and a second opposing sides;

a neural interface attached to the PCB;

a core subsystem (CSS) attached to the first side of the PCB and electrically connected to the neural interface;

a radio frequency (RF) interface attached to the PCB and electrically connected to the CSS; and

an external programmable controller configured to power and control the implant,

wherein the core subsystem is configured to select a trained waveform from memory and start stimulation by providing an electrical signal to the neural interface upon receiving a request to enter into a stimulation state, and

wherein the core subsystem is configured to report completion of a stimulation state to the controller via an RF communication and go to an idle state.

2. The system of claim 1 , further comprising a plurality of individual electrodes.

3. The system of claim 1 , wherein the implant is configured to provide stimulation to the HGN at preprogrammed conditions.

4. The system of claim 1 , wherein the core subsystem being included in a silicon chip attached to the PCB with the chip connected to the neural interface via traced wires printed on the PCB.

5. The system of claim 1 , wherein the silicon chip is configured to be powered by and receive a customized electrode stimulation program protocol from the controller.

6. The system of claim 1 , further comprising a matrix of electrodes coupled to one or more fascicles or regions of the HGN.

7. The system of claim 1 , wherein the supplied power includes RF energy emitted by the controller.

8. The system of claim 1 , wherein the controller is configured to stimulate patient specific nerve physiology and stimulation parameters.

9. The system of claim 1 , wherein the controller is shaped for placement around a patient's ear.

10. The system of claim 1 , wherein the controller is configured to:

identify an implant having a unique ID tag;

communicate with the implant having the unique ID tag; and

send a signal to a transponder located in the implant.

11. The system of claim 1 , wherein the controller is configured to:

provide an RF signal to the implant;

sense and record data; and

interface with a programming device.

12. The system of claim 1 , wherein the controller is configured to communicate with the implant at preprogrammed intervals.

13. The system of claim 1 , wherein the implant is configured to provide continuous open loop electrical stimulation to the HGN during sleep hours.

14. The system of claim 1 , wherein the implant is configured to deliver multiple modes of stimulation.

15. The system of claim 1 , wherein the implant is configured to provide stimulation in multiple dimensions.

16. Previously Presented) The system of claim 1 , wherein the neural interface does not include external wires or leads.

17. The system of claim 1 , wherein the neural interface is configured to stimulate the HGN.

18. The system of claim 1 , wherein the neural interface is configured to sense neural activity of the nerve it interfaces with and transmit that sensed neural activity to the core subsystem.

19. An implantable neurostimulator system for treating obstructive sleep apnea, comprising:

an implant having a top and a bottom layer, the bottom layer serving as an attachment mechanism such that the bottom layer of the implant is adapted to be coupled to and at least partially surround a Hypoglossal nerve (HGN) and attaches to the top layer of the implant;

a printed circuit board (PCB) attached to the top layer of the implant, the PCB having a first and a second opposing sides;

a neural interface attached to the PCB;

a core subsystem (CSS) attached to the first side of the PCB and electrically connected to the neural interface;

a radio frequency (RF) interface attached to the PCB and electrically connected to the CSS; and

an external programmable controller configured to power and control the implant,

wherein the core subsystem being included in a silicon chip attached to the PCB with the chip connected to the neural interface via traced wires printed on the PCB.

20. The system of claim 19 , further comprising a plurality of individual electrodes.

21. The system of claim 19 , wherein the implant is configured to provide stimulation to the HGN at preprogrammed conditions.

22. The system of claim 19 , wherein the silicon chip is configured to be powered by and receive a customized electrode stimulation program protocol from the controller.

23. The system of claim 19 , further comprising a matrix of electrodes coupled to one or more fascicles or regions of the HGN.

24. The system of claim 19 , wherein the core subsystem is configured to select a trained waveform from memory and start stimulation by providing an electrical signal to the neural interface upon receiving a request to enter into a stimulation state.

25. The system of claim 19 , wherein the supplied power includes RF energy emitted by the controller.

26. The system of claim 19 , wherein the controller is configured to stimulate patient specific nerve physiology and stimulation parameters.

27. The system of claim 19 , wherein the controller is shaped for placement around a patient's ear.

28. The system of claim 19 , wherein the controller is configured to:

identify an implant having a unique ID tag;

communicate with the implant having the unique ID tag; and

send a signal to a transponder located in the implant.

29. The system of claim 19 , wherein the controller is configured to:

provide an RF signal to the implant;

sense and record data; and

interface with a programming device.

30. The system of claim 19 , wherein the controller is configured to communicate with the implant at preprogrammed intervals.

31. The system of claim 19 , wherein the implant is configured to provide continuous open loop electrical stimulation to the HGN during sleep hours.

32. The system of claim 19 , wherein the implant is configured to deliver multiple modes of stimulation.

33. The system of claim 19 , wherein the implant is configured to provide stimulation in multiple dimensions.

34. The system of claim 19 , wherein the neural interface does not include external wires or leads.

35. The system of claim 19 , wherein the neural interface is configured to stimulate the HGN.

36. The system of claim 19 , wherein the neural interface is configured to sense neural activity of the nerve it interfaces with and transmit that sensed neural activity to the core subsystem.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: IMTHERA MEDICAL, INC.
Reel/Frame 057535/0850 →
SECURITY INTEREST Recorded Aug 16, 2021
From: IMTHERA MEDICAL, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0115 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: IMTHERA MEDICAL, INC.
Reel/Frame 057188/0573 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: IMTHERA MEDICAL, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0683 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: IMTHERA MEDICAL, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 052963/0651 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2010
From: LIMA, MARCELO G.; CRAIG, STANLEY R.
To: IMTHERA MEDICAL, INC.
Reel/Frame 024179/0788 →
Continuity (5)
Continuation 11707053 · Feb 16, 2007
Provisional Application 60774039 · Feb 16, 2006
Provisional Application 60774040 · Feb 16, 2006
Provisional Application 60774041 · Feb 16, 2006
Related Publication 20100198306A1 · Aug 5, 2010